# Unchained Labs

Unchained Labs is an Asset Manager based in Pleasanton, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Pleasanton, United States
- **Region:** North America
- **Address:** 4747 Willow Rd, Pleasanton, CA 94588, United States
- **Assets under management:** Undisclosed
- **Website:** unchainedlabs.com
- **LinkedIn:** https://www.linkedin.com/company/unchained-labs

## Regulatory record

- **Reports private funds:** No

## About

Unchained Labs helps biologics & gene therapy researchers break free from tools that don't cut it. Crank up your research with our problem-solving products.

## Sectors

- Life Sciences
- Biotech Tools

## Offices

- Brighton, MA
- Gent, Belgium
- Royston, UK
- Shanghai, China
- Tokyo, Japan

## People

- Tim Harkness — Founder and CEO
- Taegen Clary — CCO
- Will Lachnit — SVP Corporate Dev
- Krista Witte — SVP Product Dev
- Dustin Giberson — SVP Operations
- Brandon Frederick — VP Finance
- Krystin Schmidt — VP Marketing
- Christie lau — Sr. Director HR
- Dr. Martin Madaus — Operating Executive, The Carlyle Group
- Robert Schmidt — Managing Director, The Carlyle Group
- Samuel Tang — Senior Associate, The Carlyle Group
- Laura J. Hamill — Biotech Executive

## Questions

### Who runs investment decisions at Unchained Labs?

Unchained Labs is not an investment firm—it is a Carlyle Group portfolio company that manufactures life-science instrumentation. Strategic and capital-allocation decisions are made by the board, which includes Founder and CEO Tim Harkness, Carlyle Operating Executive Dr. Martin Madaus, and Carlyle Managing Director Robert Schmidt. Carlyle's U.S. Buyout team, based in New York, oversees the investment from the sponsor side.

### How does Unchained Labs source its proprietary deal flow?

The firm does not source deal flow in the allocator sense. Its growth comes from internal product development, not acquisitions of portfolio companies. The R&D pipeline is built through identifying unsolved benchtop problems in biologics and gene therapy workflows, then engineering plate-based or automated instruments to replace manual protocols.

### Does Unchained Labs participate in fund commitments or direct deals?

No. Unchained Labs is an operating company, not an institutional allocator or LP. It does not make fund commitments, direct equity investments, or co-investments. Its capital deployment is entirely directed toward product development, manufacturing, and geographic expansion of its commercial organization.

## Related profiles

- [Visier](https://altss.com/profile/visier)
- [Sourcenext](https://altss.com/profile/sourcenext)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/unchained-labs

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology